Stay updated with breaking news from Immunicum Ab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Immunicum AB, Correction: Immunicum AB: Immunicum AB (publ) Announces Q4 and Year-End Results 2021
10.02.2022 - Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical company focused on the prevention of cancer recurrence and addressing hard-to-treat tumors, will publish its financial results for the fourth quarter and full year ended December 31, 2021 ...
Investegate announcements from Immunicum AB, Immunicum AB: Invitation to Immunicum's Full-Year 2021 Review and Pipeline and Strategy Outlook Held as a Hybrid Event on February 17, 2022
Investegate announcements from Immunicum AB, Immunicum to Participate in Upcoming Investor and Industry Conferences in January
Investegate announcements from Immunicum AB, Immunicum to Present Data Update on Phase II ADVANCE II at Annual American Society of Hematology Meeting (ASH)